Mounjaro 12.5mg

Mounjaro 12.5 mg is a once-weekly injectable medication used to treat type 2 diabetes and support weight loss. It contains tirzepatide, which activates two hormones (GIP and GLP‑1) to improve blood sugar control, reduce appetite, and slow digestion. The 12.5 mg dose is typically used after patients have progressed through lower doses and need stronger effects. It comes in a prefilled pen and is injected under the skin. Common side effects include nausea, diarrhea, and reduced appetite.